SAMANTHA MCGILL: Open Payments
NPI 1962741223 · OCEAN SPRINGS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,811 in 98 payments from 16 companies in 2025. Trend: 2023 $2,099 · 2024 $1,929 · 2025 $1,811
Food & beverage: $1,811
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 13 | $312 |
| Novo Nordisk Inc | 17 | $279 |
| Lilly USA, LLC | 17 | $252 |
| Dexcom, Inc. | 14 | $248 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $184 |
| Xeris Pharmaceuticals, Inc. | 5 | $103 |
| Medtronic, Inc. | 4 | $83 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| Averitas Pharma Inc. | 2 | $59 |
| Corcept Therapeutics | 3 | $53 |
Products named: FREESTYLE LIBRE, Ozempic, MOUNJARO, Dexcom G6 Transmitter, Kerendia, MINIMED 780G, RECORLEV, LEQVIO.
Industry payments across MS — which companies pay providers there.
